(Q28209992)

2

0 references

Takayuki Harada

3

0 references

Koichi Shimode

4

0 references

Hiromi Takeuchi

5

0 references

Yohko Murakawa

6

0 references

Makoto Nagasaki

7

0 references

Akinobu Nakano

8

0 references

Shotai Kobayashi

Leptomeningeal carcinomatosis. Presenting features and prognostic factors.

9

0 references

language of work or name

English

0 references

publication date

March 2003

0 references

published in

Clinica Chimica Acta

0 references

volume

329

0 references

issue

1-2

0 references

page(s)

53-60

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Neurologic Complications of Systemic Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Neurologic Complications of Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Molecular aspects of tumor cell invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Cathepsin B, Cathepsin H, and cathepsin L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Diagnosis of cerebral amyloid angiopathy by enzyme-linked immunosorbent assay of cystatin C in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Synthesis of cathepsin B by cells derived from the HL60 promyelocytic leukaemia cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8

CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900023-8